Home
About
About HEPC
What We Do
Who We Are
Patients
Find Treatment
In Treatment
Referral on Release
Patient Resources
Partners
Training
HEPC Clinician and Staff Training
HEPC and UW Hepatitis C Online
Past Training
Community of Practice
COP Information
COP Galleries
Clinicians
Resources
Telemedicine Connection
Referral on Release Program
Screening and Treating Report
Consultations
Sentara
News
Treatment Access Map
Research
Contact

Virginia HEPC

Home
About
About HEPC
What We Do
Who We Are
Patients
Find Treatment
In Treatment
Referral on Release
Patient Resources
Partners
Training
HEPC Clinician and Staff Training
HEPC and UW Hepatitis C Online
Past Training
Community of Practice
COP Information
COP Galleries
Clinicians
Resources
Telemedicine Connection
Referral on Release Program
Screening and Treating Report
Consultations
Sentara
News
Treatment Access Map
Research
Contact
SEPTEMBER 2023 PRIMER: HCV Resistance Testing

SEPTEMBER 2023 PRIMER: HCV Resistance Testing

AUGUST 2023 VIDEO: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 VIDEO: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 ARTICLE: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 ARTICLE: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

JULY 2023 RECORDING: Early Adherence Assessment in Minimal Monitoring

JULY 2023 RECORDING: Early Adherence Assessment in Minimal Monitoring

JULY 2023 PRESENTATION: Early Adherence Assessment in Minimal Monitoring

JULY 2023 PRESENTATION: Early Adherence Assessment in Minimal Monitoring

MAY 2023 RECORDING: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 RECORDING: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 PRESENTATION: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 PRESENTATION: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 ARTICLE: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 ARTICLE: Retreatment of HCV after Treating with Direct Acting Antivirals

APRIL 2023 RECORDING: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 RECORDING: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 PRESENTATION: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 PRESENTATION: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

MARCH 2023 RECORDING: Occupational Exposure to HCV

MARCH 2023 RECORDING: Occupational Exposure to HCV

MARCH 2023 PRESENTATION: Occupational Exposure to HCV

MARCH 2023 PRESENTATION: Occupational Exposure to HCV

MARCH 2023 REPORT: Occupational Exposure to HCV

MARCH 2023 REPORT: Occupational Exposure to HCV

FEBRUARY 2023 RECORDING: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 RECORDING: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Previous Next
SEPTEMBER 2023 PRIMER: HCV Resistance Testing
AUGUST 2023 VIDEO: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP
AUGUST 2023 ARTICLE: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP
JULY 2023 RECORDING: Early Adherence Assessment in Minimal Monitoring
JULY 2023 PRESENTATION: Early Adherence Assessment in Minimal Monitoring
MAY 2023 RECORDING: Retreatment of HCV after Treating with Direct Acting Antivirals
MAY 2023 PRESENTATION: Retreatment of HCV after Treating with Direct Acting Antivirals
MAY 2023 ARTICLE: Retreatment of HCV after Treating with Direct Acting Antivirals
APRIL 2023 RECORDING: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations
APRIL 2023 PRESENTATION: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations
APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations
APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations
MARCH 2023 RECORDING: Occupational Exposure to HCV
MARCH 2023 PRESENTATION: Occupational Exposure to HCV
MARCH 2023 REPORT: Occupational Exposure to HCV
FEBRUARY 2023 RECORDING: A minimal monitoring approach for the treatment of hepatitis C virus infection
FEBRUARY 2023 ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection
Back to Top